Infectious Disease Testing Market in U.S. to Expand at 5.81% CAGR by 2019 Boosted by Growing Prevalence of AIDS

Published Date : Jul 05, 2016

ALBANY, NY, July 05, 2016: has added a new report on the infectious disease testing market in the U.S. The report, titled “Infectious Disease Testing Market In The US 2015-2019,” describes the present scenario of the this market in the U.S. and identifies the key factors impacting the growth of the market. The report projects the U.S. infectious disease testing market to expand at a CAGR of 5.81% during the period between 2014 and 2019. The overall market has been studied on the basis of technology and application. To describe the competitive landscape, the report profiles some of the major players operating in the market.

According to the Centers for Disease Control and Prevention, over 1.2 million patients in the U.S. are infected with HIV and one in eight patients are unaware about their condition. While 47,352 people were diagnosed with HIV in 2013, around 26,688 were affected with AIDS in the same year. Early diagnosis and effective treatment play a pivotal role in preventing the long-term adverse complications of HIV and AIDS. Infectious diseases threaten public health and lead to the increasing costs of healthcare. The introduction of various technologies for screening and detection of infectious diseases such as HIV has propelled the growth of the infectious disease testing market in the U.S.

The report identifies that the free trade agreement across North America has emerged as one of the primary factors driving the growth of the U.S. infectious disease testing market. However, the introduction of the medical device excise tax law is anticipated to impede the growth of the market during the forecast horizon. The overall market has a significant opportunity to grow with the development of innovative diagnostic initiatives.

For Sample Copy, click here:

On the basis of technology, the U.S. infectious disease testing market has been segmented into immunodiagnostic test, molecular diagnostic test, and POCT. In terms of application, the POCT diagnostic devices have been sub-segmented into respiratory, HIV, HAIs, tropical diseases, sexual health, and hepatitis. The report analyzes the demand for each of the diagnostic technologies during the forecast horizon. Furthermore, the report studies the regional infectious disease testing market on the basis of products such as consumables and equipment.

Some of the key players in the U.S. infectious disease testing market are Abbott Diagnostics, Beckman Coulter Diagnostics, Alere, Siemens Healthcare, Roche, Bio-Rad Laboratories, Acon Laboratories, Chembio Diagnostic Systems, Abaxis, Clarity Diagnostics, Gold Standard Diagnostics, Epitope Diagnostic, Hologic, Life Technologies, Thermo Fisher Scientific, Trinity Biotech, Quidel Corporation, Ortho Clinical Diagnostics, Immunetics, InBios International, OraSure Technologies, and Maxim Biomedical, Mindray. The report offers insights about the market players including their revenue, product portfolio, and recent developments. Furthermore, the various market opportunities and threats faced by the key players have been analyzed in the report.

To order report Call Toll Free: 866-997-4948 or send an email on